ALLR (Allarity Therapeutics) OCF Margin %: -17,972.00% (As of Mar. 2026)


ALLR Allarity Therapeutics Inc ALLR
24 GF Score
Price $1.28
! 2 Warning Signs
View Full Analysis

What is Allarity Therapeutics OCF Margin %?

Allarity Therapeutics ALLR -2.31% 24 OCF Margin % is -17,972.00% as of Mar. 2026. GuruFocus rates ALLR with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Allarity Therapeutics ranks worse than 90.51% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Allarity Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-4.49 Mil. Allarity Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.03 Mil. Therefore, Allarity Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was -17,972.00%.

As of today, Allarity Therapeutics's current OCF Yield % is -81.64%.

The historical rank and industry rank for Allarity Therapeutics's OCF Margin % or its related term are showing as below:

ALLR' s OCF Margin % Range Over the Past 10 Years
Min: -8427.5   Med: -6529.38   Max: -4631.25
Current: -4819.42

During the past 7 years, the highest OCF Margin % of Allarity Therapeutics was -4631.25%. The lowest was -8427.50%. And the median was -6529.38%.

ALLR's OCF Margin % is ranked worse than
90.51% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs ALLR: -4819.42

Allarity Therapeutics OCF Margin % Related Terms

Allarity Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Allarity Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allarity Therapeutics OCF Margin % Chart

Allarity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -4,631.25

Allarity Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1,013.44 -17,972.00

ALLR vs OTLC, MRKR, SKYE: OCF Margin % Comparison

For the Biotechnology subindustry, Allarity Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allarity Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Allarity Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Allarity Therapeutics's OCF Margin % falls into.


ALLR
24GF Score
Allarity Therapeutics Inc ALLR
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allarity Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Allarity Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-14.82/0.32
=-4,631.25 %

Allarity Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.493/0.025
=-17,972.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -17,972.00% mean?
Allarity Therapeutics (ALLR) has a OCF Margin % of -17,972.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Allarity Therapeutics and its competitors. According to the industry distribution chart, Allarity Therapeutics ranks #868 out of 959 companies in the Biotechnology industry, placing it in the top 90.5%.
Is Allarity Therapeutics' OCF Margin % too high?
Allarity Therapeutics' current OCF Margin % is -17,972.00%. Based on the distribution chart, Allarity Therapeutics ranks #868 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Allarity Therapeutics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Allarity Therapeutics' OCF Margin % compare to OTLC and MRKR?
According to the Biotechnology industry distribution chart, Allarity Therapeutics ranks #868 out of 959 companies for OCF Margin %. This places Allarity Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Allarity Therapeutics and its competitors. Allarity Therapeutics's current OCF Margin % is -17,972.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allarity Therapeutics stock overvalued right now?
Allarity Therapeutics (ALLR) has a current OCF Margin % of -17,972.00%. The current OCF Margin % is -17,972.00%. Allarity Therapeutics' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Allarity Therapeutics (ALLR), the current OCF Margin % is -17,972.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Allarity Therapeutics Business Description

Address 123 East Tarpon Avenue, Tarpon Springs, FL, USA, 34689
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
24GF Score

Get the complete analysis for ALLR

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.28
Price